Chemoinformaics analysis of (3Z,6Z,9Z)-DODECATRIENOL
Molecular Weight | 180.291 | nRot | 7 |
Heavy Atom Molecular Weight | 160.131 | nRig | 3 |
Exact Molecular Weight | 180.151 | nRing | 0 |
Solubility: LogS | -2.93 | nHRing | 0 |
Solubility: LogP | 3.598 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 34.1779 |
nHD | 1 | BPOL | 20.0641 |
QED | 0.596 |
Synth | 2.989 |
Natural Product Likeliness | 1.873 |
NR-PPAR-gamma | 0.343 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.032 |
HIA | 0.005 |
CACO-2 | -4.398 |
MDCK | 0.000117095 |
BBB | 0.879 |
PPB | 0.695998 |
VDSS | 0.947 |
FU | 0.212026 |
CYP1A2-inh | 0.585 |
CYP1A2-sub | 0.152 |
CYP2c19-inh | 0.073 |
CYP2c19-sub | 0.072 |
CYP2c9-inh | 0.024 |
CYP2c9-sub | 0.81 |
CYP2d6-inh | 0.014 |
CYP2d6-sub | 0.196 |
CYP3a4-inh | 0.265 |
CYP3a4-sub | 0.114 |
CL | 12.898 |
T12 | 0.801 |
hERG | 0.003 |
Ames | 0.651 |
ROA | 0.003 |
SkinSen | 0.964 |
Carcinogencity | 0.364 |
EI | 0.994 |
Respiratory | 0.481 |
NR-Aromatase | 0.015 |
Antiviral | No |
Prediction | 0.713924 |